“Detection and Management of Signals Associated With Adverse Drug Reactions from Atorvastatin and Rosuvastatin: An Observational Study”. 2025. Vascular and Endovascular Review 8 (17s): 279-84. https://verjournal.com/index.php/ver/article/view/1272.